* Dynavax Technologies Corp DVAX.OQ reported quarterly
adjusted
earnings of 43 cents per share for the quarter ended in
September. The mean expectation of five analysts for the quarter
was for earnings of 33 cents per share.
* Revenue rose 54.9% to $167.74 million from a year ago;
analysts
expected $159.41 million.
* The mean earnings estimate of analysts had fallen by
about 3.7%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Dynavax Technologies Corp shares had risen by 8.0% this
quarter and lost 19.9% so far this year.
* Wall Street's median 12-month price target for Dynavax
Technologies Corp is $24.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data November
3 at 09:03 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2022 0.33 0.43 Beat
Jun. 30 2022 0.22 0.87 Beat
Mar. 31 2022 0.24 0.22 Missed
Dec. 31 2021 0.64 0.55 Missed